Company
MDCX · CIK 0001997296
Acquisition (code A) of 2,941,176 shares at $0.1705 per share.
Reporting Person Bokhari Raza · Officer Title Chief Executive Officer · Transaction Code A
Traded Sep 4, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0000950142-26-002518 · filed 2026-09-08 · View filing →
Acquisition (code A) of 1,470,588 shares at $0.1705 per share.
Reporting Person Bonner Carolyn F. · Officer Title President and CFO · Transaction Code A
Traded Sep 4, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0000950142-26-002519 · filed 2026-09-08 · View filing →
Acquisition (code A) of 588,235 shares at $0.1705 per share.
Reporting Person Brennan Edward J. · Officer Title Chief Scientific Officer · Transaction Code A
Traded Sep 4, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0000950142-26-002520 · filed 2026-09-08 · View filing →
Acquisition (code A) of 1,470,588 shares at $0.1705 per share.
Reporting Person Mehmud Faisal · Officer Title Chief Medical Officer · Transaction Code A
Traded Sep 4, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0000950142-26-002521 · filed 2026-09-08 · View filing →
Acquisition (code A) of 735,294 shares at $0.1705 per share.
Reporting Person Smith Andrew Alasdair · Officer Title Chief Operating Officer · Transaction Code A
Traded Sep 4, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0000950142-26-002522 · filed 2026-09-08 · View filing →